Growth Metrics

Integer Holdings (ITGR) Liabilities and Shareholders Equity (2010 - 2026)

Integer Holdings recorded quarterly Liabilities and Shareholders Equity of $3.4 billion in Q2 2026, little changed quarter-over-quarter from $3.4 billion in Q4 2025, and up 3.46% year-over-year from $3.3 billion in Q2 2025.

Integer Holdings' Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $3.4 billion for Q2 2026.

  • In Q2 2026, Liabilities and Shareholders Equity rose 3.46% year-over-year to $3.4 billion; the TTM figure through Apr 2026 stood at $13.6 billion (up 7.27% YoY), while the FY2025 annual figure was $3.4 billion, up 10.81% from the prior year.
  • Liabilities and Shareholders Equity came in at $3.4 billion for Q2 2026 at Integer Holdings, roughly flat from $3.4 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.4 billion in Q2 2026 to a low of $2.6 billion in Q2 2022.
  • A 5-year average of $3.0 billion and a median of $3.1 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity advanced 16.91% in 2022 and climbed 3.46% in 2026, its largest moves.
  • Integer Holdings' Liabilities and Shareholders Equity stood at $2.8 billion in 2022, then climbed by 5.31% to $2.9 billion in 2023, then rose by 4.6% to $3.1 billion in 2024, then grew by 10.81% to $3.4 billion in 2025, then climbed by 0.03% to $3.4 billion in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $3.4 billion, $3.4 billion, and $3.4 billion for Q2 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 110.43 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 46.29 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 37.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 10.74 Bn
10 Integer Holdings 3.11 Bn 3.11 Bn 109.60 Mn 3.41 Bn

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 3.41 Bn
Dec 31, 2025 3.41 Bn
Sep 26, 2025 3.40 Bn
Jun 27, 2025 3.37 Bn
Mar 28, 2025 3.30 Bn
Dec 31, 2024 3.08 Bn
Sep 27, 2024 3.17 Bn
Jun 28, 2024 3.13 Bn
Mar 29, 2024 3.12 Bn
Dec 31, 2023 2.94 Bn
Sep 29, 2023 2.84 Bn
Jun 30, 2023 2.86 Bn
Mar 31, 2023 2.87 Bn
Dec 31, 2022 2.79 Bn
Sep 30, 2022 2.74 Bn
Jul 1, 2022 2.76 Bn
Apr 1, 2022 2.61 Bn
Dec 31, 2021 2.58 Bn
Oct 1, 2021 2.35 Bn
Jul 2, 2021 2.36 Bn
Apr 2, 2021 2.34 Bn
Dec 31, 2020 2.37 Bn
Oct 2, 2020 2.45 Bn
Jul 3, 2020 2.52 Bn
Apr 3, 2020 2.40 Bn
Dec 31, 2019 2.35 Bn
Sep 27, 2019 2.36 Bn
Jun 28, 2019 2.37 Bn
Mar 29, 2019 2.37 Bn
Dec 28, 2018 2.33 Bn
Sep 28, 2018 2.36 Bn
Jun 29, 2018 2.81 Bn
Mar 30, 2018 2.85 Bn
Dec 29, 2017 2.85 Bn
Sep 29, 2017 2.85 Bn
Jun 30, 2017 2.84 Bn
Mar 31, 2017 2.84 Bn
Dec 30, 2016 2.83 Bn
Sep 30, 2016 2.88 Bn
Jul 1, 2016 2.90 Bn
Apr 1, 2016 2.91 Bn
Jan 1, 2016 2.98 Bn
Oct 2, 2015 983.62 Mn
Jul 3, 2015 966.13 Mn
Apr 3, 2015 946.72 Mn
Jan 2, 2015 955.12 Mn
Oct 3, 2014 931.29 Mn
Jul 4, 2014 911.77 Mn
Apr 4, 2014 890.38 Mn
Jan 3, 2014 889.63 Mn
Sep 27, 2013 884.71 Mn
Jun 28, 2013 897.28 Mn
Mar 29, 2013 884.92 Mn
Dec 28, 2012 889.88 Mn
Sep 28, 2012 891.93 Mn
Jun 29, 2012 885.79 Mn
Mar 30, 2012 886.99 Mn
Dec 30, 2011 881.35 Mn
Sep 30, 2011 811.84 Mn
Jul 1, 2011 819.92 Mn
Dec 31, 2010 776.98 Mn